These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Measuring movement disorders in antipsychotic drug trials: the need to define a new standard. Loonen AJ; van Praag HM J Clin Psychopharmacol; 2007 Oct; 27(5):423-30. PubMed ID: 17873670 [No Abstract] [Full Text] [Related]
23. [When does the extrapyramidal syndrome become an adverse reaction to major psychotropic drugs? ]. Csiky K Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1978; 23(2):131-4. PubMed ID: 30159 [No Abstract] [Full Text] [Related]
24. [Neuroleptics and tranquilizers: indications and dangers]. Möller HJ Med Klin (Munich); 1986 May; 81(11):385-8. PubMed ID: 2878353 [No Abstract] [Full Text] [Related]
25. The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics. Spohn HE; Coyne L Brain Cogn; 1993 Sep; 23(1):28-39. PubMed ID: 8105820 [TBL] [Abstract][Full Text] [Related]
27. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. Casey DE Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453 [TBL] [Abstract][Full Text] [Related]
28. Cigarette smoking is associated with abnormal involuntary movements in the general male population--a study of men born in 1933. Nilsson A; Waller L; Rosengren A; Adlerberth A; Wilhelmsen L Biol Psychiatry; 1997 Mar; 41(6):717-23. PubMed ID: 9066996 [TBL] [Abstract][Full Text] [Related]
29. Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment. Schwartz M; Weller B; Erdreich M; Sharf B J Clin Psychiatry; 1995 May; 56(5):212. PubMed ID: 7737962 [No Abstract] [Full Text] [Related]
30. Quetiapine as treatment for dopaminergic-induced dyskinesias in Parkinson's disease. Baron MS; Dalton WB Mov Disord; 2003 Oct; 18(10):1208-9. PubMed ID: 14534933 [No Abstract] [Full Text] [Related]
31. ECT and tardive dyskinesia: two cases and a review. Chacko RC; Root L J Clin Psychiatry; 1983 Jul; 44(7):265-6. PubMed ID: 6134719 [TBL] [Abstract][Full Text] [Related]
32. [Therapeutic trial of gamma-vinyl GABA, an inhibitor of GABA transaminase, in tardive dyskinesias induced by neuroleptics]. Lambert PA; Cantiniaux P; Chabannes JP; Tell GP; Schechter PJ; Koch-Weser J Encephale; 1982; 8(3):371-6. PubMed ID: 6137357 [TBL] [Abstract][Full Text] [Related]
33. Prolactin response to neuroleptics. Clinical and theoretical implications. Ohman R; Axelsson R J Neural Transm Suppl; 1980; 17():1-74. PubMed ID: 6133911 [No Abstract] [Full Text] [Related]
34. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. Kane JM J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107 [TBL] [Abstract][Full Text] [Related]
35. Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia. Pourcher E; Cohen H; Cohen D; Baruch P; Bouchard RH Brain Cogn; 1993 Sep; 23(1):81-7. PubMed ID: 8105825 [TBL] [Abstract][Full Text] [Related]
36. Treatment of neuroleptic-induced tardive dyskinesia with levetiracetam: a case series. Bona JR J Clin Psychopharmacol; 2006 Apr; 26(2):215-6. PubMed ID: 16633158 [No Abstract] [Full Text] [Related]
38. Risperidone and tardive dyskinesia: a case report. Addington DE; Toews JA; Addington JM J Clin Psychiatry; 1995 Oct; 56(10):484-5. PubMed ID: 7559377 [No Abstract] [Full Text] [Related]
39. Use of antipsychotic medication in the elderly. Maletta GJ Annu Rev Gerontol Geriatr; 1984; 4():175-220. PubMed ID: 6152711 [No Abstract] [Full Text] [Related]
40. Update on legal issues associated with tardive dyskinesia. Slovenko R J Clin Psychiatry; 2000; 61 Suppl 4():45-57. PubMed ID: 10739331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]